Gonadorelin (GnRH)
Sourcing GuideProcurement-quality evaluation of Gonadorelin (GnRH) centres on six markers: lot-specific COA availability, HPLC purity ≥98%, mass spec confirmation matching 1182 Da, endotoxin testing for injectable routes, vendor regulatory disclosure, and cold-chain shipping options. Binds the GnRH receptor on anterior pituitary gonadotrophs in a pulsatile fashion to stimulate LH (and to a lesser extent FSH) release The pulsatile pattern is critical: continuous exposure desensitises and downregulates the receptor (the basis of GnRH-agonist chemical castration drugs).. The QC discipline applies regardless of the application; sourcing standards do not relax for any particular use case.
Key Takeaways
Procurement lens: Gonadorelin (GnRH) sourcing requires lot-specific COA, HPLC purity ≥98%, mass spec confirmation matching 1182 Da. Mechanism: Binds the GnRH receptor on anterior pituitary gonadotrophs in a pulsatile fashion to stimulate LH (and to a lesser extent FSH) release. Storage: lyophilised at -20°C for 18-24 months; reconstituted at 4°C for 14-28 days. Vendor tier: pharmaceutical-grade compounded > reputable research-grade > grey-market (3-5x cost differential; quality differential substantially larger). Sourcing-validated stack partners: BPC-157, TB-500, GHK-Cu.
Binds the GnRH receptor on anterior pituitary gonadotrophs in a pulsatile fashion to stimulate LH (and to a lesser extent FSH) release. The pulsatile pattern is critical: continuous exposure desensitises and downregulates the receptor (the basis of GnRH-agonist chemical castration drugs). Sourcing implications: the mechanism dictates which analytical assays are appropriate for QC, which storage conditions preserve activity, and which reconstitution and use practices matter. The subsections below cover HPLC and analytical identity, COA evaluation and red flags, reconstitution and storage, and vendor tier comparison for Gonadorelin (GnRH).
COA evaluation and red flags
Acceptable Gonadorelin (GnRH) certificates of analysis specify: (1) lot number matching the vial, (2) HPLC purity with chromatographic trace, (3) mass spec confirmation, (4) endotoxin testing for SubQ-route use, and (5) issuance from an accredited third-party laboratory. Template COAs that cannot be traced to a specific lot, COAs missing endotoxin data for injectable material, and COAs issued by the vendor's own laboratory rather than a third party are all sourcing red flags.
HPLC purity and analytical identity
Minimum acceptable HPLC purity for Gonadorelin (GnRH) is ≥98% in research-grade material. Mass spec confirmation should show the characteristic m/z of 1182 (M+H)+. Contaminant peaks above 1% in the HPLC trace warrant quantification on the COA and — ideally — structural identification of the major impurities.
Vendor tier comparison and price discipline
Three vendor tiers operate in the Gonadorelin (GnRH) market: pharmaceutical-grade compounded prescription (physician-supervised, full COA, ICP-MS where relevant, highest cost), reputable research-chemical vendors (full COA, lot-specific, mid-tier cost), and grey-market unverified sources (template or absent COA, unverifiable supply chain, lowest cost). The price differential between tiers is roughly 3–5x; the quality differential is substantially larger and concentrated in the bottom tier.
Sourcing Gonadorelin (GnRH) for cold chain use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.
For users targeting storage protocol, the sourcing question is whether the chosen vendor consistently delivers analytical-spec material across lots. Repeated re-orders from the same vendor with mid-cycle COA spot-checks is the procurement pattern that catches lot drift before it affects results.
Pharmaceutical-grade compounded Gonadorelin (GnRH) is the lowest-risk sourcing path for reconstitution guide use where the route permits, particularly for users with clinical supervision. Research-grade material from accredited vendors is the practical alternative; grey-market sourcing is not appropriate for this application.
Sourcing Gonadorelin (GnRH) for bac water sourcing use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.
| Goal | Route | Dose | Cycle |
|---|---|---|---|
| Standard protocol | SubQ | 50-200 mcg | 8–12 weeks on / 4 weeks off |
| Conservative starter | SubQ | 30-200 mcg | 4–6 weeks initial cycle |
| Sourcing Guide focus | SubQ | 50-200 mcg | Every other day, mimicking pulsatile release |
| Maintenance phase | SubQ | 35-200 mcg | Ongoing with periodic pauses |
Dose timing for Gonadorelin (GnRH) is important relative to food and training given the short half-life. Consistency through the cycle is more important than the precise clock time of individual doses.
Gonadorelin (GnRH) stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from experienced peptide buyers.
- Gonadorelin (GnRH) + BPC-157: Upregulates VEGFR2 to promote angiogenesis and activates the FAK-paxillin pathway for accelerated tissue repair. Pairs naturally with Gonadorelin (GnRH)'s mechanism in sourcing / quality / procurement protocols.
- Gonadorelin (GnRH) + TB-500: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. Pairs naturally with Gonadorelin (GnRH)'s mechanism in sourcing / quality / procurement protocols.
- Gonadorelin (GnRH) + GHK-Cu: GHK chelates copper(II) and acts as a transcriptional modulator: published microarray data show it influences over 4,000 human genes including resetting expression patterns toward younger cellular phenotypes. Pairs naturally with Gonadorelin (GnRH)'s mechanism in sourcing / quality / procurement protocols.
- Gonadorelin (GnRH) + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with Gonadorelin (GnRH)'s mechanism in sourcing / quality / procurement protocols.
Generally well tolerated. Headache and injection site reactions occasional. Continuous (non-pulsatile) administration causes paradoxical suppression — dose timing matters.
Lens-specific safety considerations for sourcing / quality / procurement use of Gonadorelin (GnRH): Generally well tolerated. Headache and injection site reactions occasional. Continuous (non-pulsatile) administration causes paradoxical suppression — dose timing matters. Additional sourcing / quality / procurement monitoring at baseline and 6–8 week follow-up is appropriate.
| Compound | Profile | Onset | Best For |
|---|---|---|---|
| Gonadorelin (GnRH) | Hypothalamic decapeptide | ~2-4 min | Sourcing Guide |
| BPC-157 | Stable gastric pentadecapeptide | ~4 hr (oral) | Accelerated tendon, ligament, and gut tissue repair via VEGFR2-driven angiogenesis and FAK-paxillin signalling |
| TB-500 | Synthetic thymosin β4 fragment | ~2-3 days | A 17-amino-acid synthetic fragment of thymosin β4 with actin-sequestering activity — drives cell migration, tissue repair, and broad regenerative effects |
| GHK-Cu | Tripeptide-copper complex | ~30 min plasma | A naturally occurring tripeptide-copper complex that declines with age and is studied for its broad effects on wound healing, skin remodelling, and gene expression |
| Ipamorelin | Selective GHRP / ghrelin mimetic | ~2 hr | The most selective ghrelin-receptor agonist among the GHRPs — stimulates GH release with minimal effect on cortisol, prolactin, or appetite |
Storage protocol?
Visual quality inspection?
Reconstitution best practices?
Pharmaceutical-grade versus research-grade?
What is the evidence base for Gonadorelin (GnRH)?
How should Gonadorelin (GnRH) be stored and reconstituted?
Start a Gonadorelin (GnRH) Protocol
Alukard provides GMP-certified physician-supervised sourcing with GMP-certified Gonadorelin (GnRH) and Pharmaceutical-grade compounds with full COA documentation.
Get ProtocolQuick Facts
- Molecular weight
- 1182 Da
- Sequence length
- 10 aa
- Half-life
- ~2-4 min
- WADA
- Not on prohibited list for males in non-IH context
- FDA
- Approved for diagnostic LH/FSH testing
- Research
- Established
Stack Partners
All sourcing / quality / procurement applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for Gonadorelin (GnRH) unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.
Start Your Sourcing / Quality / Procurement Protocol for Gonadorelin (GnRH)
Alukard provides GMP-certified physician-supervised sourcing with Pharmaceutical-grade compounds with full COA documentation.
HIPAA Compliant · GMP Certified · Physician Supervised